ロード中...
Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action
BACKGROUND: Critically ill COVID-19 patients have a clear pattern of inflammation and hypercoagulable state. The main aim of the study was to evaluate the outcome of severe COVID-19 patients basing on prothrombotic risk factors (i.e. D-dimer). We also evaluated the impact of different doses of low m...
保存先:
| 出版年: | Thromb Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Ltd.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7487146/ https://ncbi.nlm.nih.gov/pubmed/32977129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2020.09.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|